Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ATNM Actinium Pharmaceuticals Inc

-0.07 (-1.33%)
Last Updated: 11:38:08
Delayed by 15 minutes


Draw Mode:

Volume 20,584
Bid Price
Ask Price
News -
Day High 5.24


52 Week Range


Day Low 5.1725
Company Name Stock Ticker Symbol Market Type
Actinium Pharmaceuticals Inc ATNM AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.07 -1.33% 5.19 11:38:08
Open Price Low Price High Price Close Price Prev Close
5.21 5.1725 5.24 5.26
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
390 20,584 $ 5.21 $ 107,183 - 4.00 - 14.70
Last Trade Time Type Quantity Stock Price Currency
11:41:23 10 $ 5.205 USD

Actinium Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
142.55M 27.41M - 1.03M -33.02M -1.20 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Actinium Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No ATNM Message Board. Create One! See More Posts on ATNM Message Board See More Message Board Posts

Historical ATNM Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.235.594.145.14208,4160.9622.7%
1 Month4.825.594.004.65177,2480.377.68%
3 Months6.806.834.005.32177,685-1.61-23.68%
6 Months8.358.754.006.43198,827-3.16-37.84%
1 Year10.4214.704.008.71253,281-5.23-50.19%
3 Years11.6515.124.008.29315,549-6.46-55.45%
5 Years0.4715.120.15061.301,886,4844.721,004.26%

Actinium Pharmaceuticals Description

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of innovative-targeted therapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest in order to kill those cells safely and effectively. Its most advanced products are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Your Recent History

Delayed Upgrade Clock